Differential Associations of PIVKA-II with Epithelial and Mesenchymal Features in HCC and PDAC
International Journal of Molecular Sciences · 05.08.2025 · 26 (15) · 7581
DOI: 10.3390/ijms26157581 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 05.08.2025. Verfasst von Antonella Farina und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Experimental Medicine, Sapienza University of Rome, Policlinico Umberto I, 00181 Rome, Italy. Hauptthemen laut MEDLINE: Epithelial-Mesenchymal Transition, Carcinoma, Hepatocellular, Liver Neoplasms, Biomarkers, Tumor. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Sapienza Bando Ateneo 2024, Sapienza University of Rome.
Abstract (Originalsprache)
Hepatocellular carcinoma (HCC) and pancreatic ductal adenocarcinoma (PDAC) are aggressive malignancies characterized by a poor prognosis and resistance to conventional therapies. Mounting evidence suggests the pivotal role of epithelial–mesenchymal transition (EMT) in tumor progression, metastasis, and therapeutic resistance in these cancers. Protein induced by vitamin K absence II (PIVKA-II)—a valuable HCC detector—has ultimately emerged as a potentially relevant biomarker in PDAC, serving as both a serum biomarker and a prognostic indicator. This study investigates the putative link between PIVKA-II expression and the EMT process in HCC and PDAC. Using a Western blot analysis and electrochemiluminescence immunoassay (ECLIA), we quantified PIVKA-II serum levels alongside two canonical EMT markers—Vimentin and E-cadherin—in selected cohorts. Emerging data suggest a dual, context-dependent role for PIVKA-II. Beyond its diagnostic value in both malignancies, its co-expression with EMT markers points to a potential mechanistic involvement in tumor invasiveness and phenotypic plasticity. Notably, the selective detection of E-cadherin in HCC implies limited EMT activation and a preservation of the epithelial phenotype, whereas the higher expression of Vimentin in PDAC reflects a more substantial shift toward EMT. We provide a comprehensive analysis of key molecular markers, their involvement in EMT-driven pathophysiological mechanisms, and their potential as novel diagnostic tools.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Experimental Medicine, Sapienza University of Rome, Policlinico Umberto I, 00181 Rome, Italy.
ORCID-Profile: Antonella Farina, Gaia Cicolani, Emanuela Anastasi
Förderung
- Sapienza Bando Ateneo 2024
- Sapienza University of Rome
Zitieren
APA
Farina, A., Cicolani, G., Viggiani, V., Matteo, M., Angeloni, A., & Anastasi, E. (2025). Differential Associations of PIVKA-II with Epithelial and Mesenchymal Features in HCC and PDAC. International Journal of Molecular Sciences, 26(15), 7581. https://doi.org/10.3390/ijms26157581
Vancouver
Farina A, Cicolani G, Viggiani V, Matteo M, Angeloni A, Anastasi E. Differential Associations of PIVKA-II with Epithelial and Mesenchymal Features in HCC and PDAC. International Journal of Molecular Sciences. 2025;26(15):7581. doi:10.3390/ijms26157581
BibTeX
@article{Farina2025,
author = {Farina, Antonella and Cicolani, Gaia and Viggiani, Valentina and Matteo, Matteo and Angeloni, Antonio and Anastasi, Emanuela},
title = {Differential Associations of PIVKA-II with Epithelial and Mesenchymal Features in HCC and PDAC},
journal = {International Journal of Molecular Sciences},
year = {2025},
volume = {26},
number = {15},
pages = {7581},
doi = {10.3390/ijms26157581}
}
EUVIMED